Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × Antioxidants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Uterine Cervical Neoplasms 1 Radiation Injuries 1 Pelvic Inflammatory Disease 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiovascular Diseases 1

Interventions

Fluorouracil 201 Leucovorin 185 Oxaliplatin 180 Irinotecan 135 Bevacizumab 98 Capecitabine 82 Cetuximab 78 Folfox protocol 52 Chemotherapy, Adjuvant 31 Panitumumab 28 pembrolizumab 22 Colonoscopy 20 Floxuridine 19 Nivolumab 18 IFL protocol 17 Gemcitabine 17 Radiotherapy 15 Drug Therapy 15 Celecoxib 15 Neoadjuvant Therapy 14 Early Intervention, Educational 14 Cyclophosphamide 14 XELOX 13 Magnetic Resonance Spectroscopy 13 Laparoscopy 13 Counseling 13 trifluridine tipiracil drug combination 12 Exercise 12 Erlotinib Hydrochloride 12 Aspirin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02231203 2018-07-31

EMPIRE

Medical Center Alkmaar

Phase 4 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡